Available until July 15, 2027 - Online CME Course

This online course consists of over 9 hours of self-paced, asynchronous education. The online content is based on current evidence-based, patient-centered standards for medical care in diabetes and includes recorded lectures and case studies. Content covers the following key topic areas: overview of diabetes, management and medications, special patient populations, complications, risk factor modifications and lifestyle management and prevention.

Online Course Through MyLearning

This course is for Mayo Clinic Personnel only

In this module you will learn about the impact of discussing sexual orientation and gender identity in patients with serious illness.

November 6 - 8, 2025 - Conrad Orlando - Orlando, Florida

This course offers Live (in-person) and Livestream (virtual) attendance options

The annual Mayo Clinic Thyroid and Parathyroid Disorders Course 2025 is a three-day CME course offering a comprehensive review of diagnostic techniques and medical and surgical management of thyroid and parathyroid disorders. Topics of discussion include the assessment of benign thyroid diseases as well as pre-and postoperative management of thyroid cancer and parathyroid disorders. Discussions include review of cutting-edge imaging modalities and diagnostic methods such as molecular testing for evaluation of thyroid nodules as well as therapeutic options for the management of benign and malignant thyroid and parathyroid conditions. This course consists of a combination of lectures and panel discussions about diagnostic and therapeutic options for management of challenging parathyroid and thyroid cases, as well as roundtable small group discussions with various experienced speakers.

February 1 - 6, 2026 - Hyatt Regency Maui - Lahaina, Maui, Hawaii

This course offers Live (in-person) and Livestream (virtual) attendance options

This comprehensive endocrinology course provides state-of-the-art updates in managing complex endocrine disorders across the lifespan. Participants will explore advances in obesity treatment, including physiologic adaptation to weight loss and novel pharmacotherapies targeting appetite regulation. The program highlights emerging evidence in thyroid disease, adrenal disorders, pituitary tumors, diabetes technologies, osteoporosis, and reproductive endocrinology. Through lectures, panels, and case-based discussions, attendees will refine their skills in diagnostic imaging, surgical considerations, and multidisciplinary care. Breakfast roundtables and expert-led sessions encourage dialogue on controversies and evolving guidelines. This course is designed for endocrinologists, internists, and allied health professionals committed to excellence in endocrine care.